Edition:
United States

Profile: Pfizer Ltd (PFIZ.NS)

PFIZ.NS on National Stock Exchange of India

1,888.30INR
2 Dec 2016
Change (% chg)

Rs-4.45 (-0.24%)
Prev Close
Rs1,892.75
Open
Rs1,900.00
Day's High
Rs1,904.00
Day's Low
Rs1,878.00
Volume
5,243
Avg. Vol
13,856
52-wk High
Rs2,548.00
52-wk Low
Rs1,610.10

Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for Anti-Allergic, Anti-Diabetic, Antihistamine, Anti-Infectives, Cardiovascular, Dermatology, Erectile Dysfunction, gastrointestinal (GI), Multivitamins, Pain/Inflammation+GI, Respiratory, Urology and Vitamin/Minerals, among others. Its products include LC-OD Plus, Bidiab, Voglibose, Histizer, Isokin, Jetex Suspension, Nebasulf Ointment, Trulimax, Combantrin A, Newsta, Selsun, Agarol, Oxileptin, Ponstan, Daxid, Tricorex, Citrosoda and Cognisules, among others. The Company has its own manufacturing facility at Thane and Goa. The Company has various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily in India.

Company Address

Pfizer Ltd

Pfizer Centre, 5, Patel Estate
Off S.V. Road, Jogeshwari (W)
MUMBAI     400051
P: +9122.66932000
F: +9122.26540274

Company Web Links